Search for: "RESEARCH PHARMACEUTICAL SERVICES, INC." Results 141 - 160 of 411
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2013, 7:45 am by Schachtman
  In In re Rigel Pharmaceuticals, Inc. [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]
23 May 2013, 5:00 am by Bexis
  We read them – well at least Bexis does, because he has to update the evidentiary chapter for his book – but usually there’s not enough there there for a blogpostNot so with Hill v Novartis Pharmaceuticals Corp., ___ F. [read post]
5 Apr 2013, 1:01 pm by Bexis
Hoffmann-LaRoche Inc., 2013 WL 1191899 (E.D.N.C. [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
George Yu, an experienced patent litigation lawyer at Schiff Hardin LLP on the legality of reverse payment settlements in the pharmaceutical sector- a strategy wherein a patent holder pays a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. [read post]
1 Mar 2013, 2:30 pm by Bexis
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
9 Jan 2013, 6:06 pm by Jessica Mendelson
Pharmaceutical Company Trade Secrets to United States Subsidiary of a Chinese Company – In January 2012, a former employee of an American pharmaceutical company, pled guilty to stealing trade secrets and making them available to an American subsidiary of a Chinese company. [read post]
31 Dec 2012, 3:29 pm by Robert B. Milligan
In late December 2012, the President signed the Theft of Trade Secrets Clarification Act, which strengthens the scope of the Economic Espionage Act to ensure it addresses the theft of trade secrets related to a product or service used or intended to be used in interstate or foreign commerce, and to prevent results like the Second Circuit’s decision in U.S. v. [read post]
31 Dec 2012, 3:29 pm by Robert B. Milligan
In late December 2012, the President signed the Theft of Trade Secrets Clarification Act, which strengthens the scope of the Economic Espionage Act to ensure it addresses the theft of trade secrets related to a product or service used or intended to be used in interstate or foreign commerce, and to prevent results like the Second Circuit’s decision in U.S. v. [read post]
21 Nov 2012, 5:00 am by Bexis
Pfizer Inc., 58 A.D.3d 138, 141 (N.Y. [read post]
24 Oct 2012, 3:51 pm by Eric Schweibenz
Ill.), filed on August 21, 2012 by KV against the Illinois Department of Healthcare and Family Services challenging the latter’s formal prior authorization policy favoring compounded HPC formulations over Makena® (parties reached settlement); and (4) K-V Pharmaceutical Company v. [read post]
15 Oct 2012, 8:13 am by Charles Johnson
  The evidence showed that from 1996 through September 2000, Edwards, the founder of ETS Payphones, Inc. [read post]
13 Sep 2012, 11:46 am by Andrew Ramonas
But Thompson, a lawyer, advised Akin health care clients that included the Pharmaceutical Research and Manufacturers of America (PhRMA), Novavax Inc. and PharmAthene Inc., the Milwaukee Journal Sentinel reported in January. [read post]